Also, Camptothecin at micromolar doses was found to sensitize these cells to a great variety of anticancer drugs in vitro and in vivo, suggesting that this drug might be repurposed to effectively treat malignant tumors with high basal NRF2 expression [23] (see Table 2). This evidence concerns the gene NFE2L2 and cancer.